To investigate whether GSTP1/2 plays a role in reducing the efficacy of BITC in human colorectal cancer cells, an experiment using human liver cancer HepG2 cells, which express GSTP1/2 only below the detection limit (Figure 1D), was conducted. This evidence concerns the gene GSTP1 and liver cancer.